Trial Profile
Comparative Study of Thymosin Beta 4 Eye Drops or Vehicle in the Treatment of Patients With Ocular Surface Defects Due to Severe Dry Eye
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2016
Price :
$35
*
At a glance
- Drugs Timbetasin (Primary)
- Indications Dry eyes
- Focus Adverse reactions; Therapeutic Use
- 23 Dec 2015 According to a RegeneRx Biopharmaceuticals media release. the final results of this trial have been posted on clinicaltrials.gov.
- 22 Dec 2015 Protocol has been amended in change in study design from single to parallel assignment, number of treatment arms from 1 to 2 and change in trial focus from TU to AR. However both TU and AR is retained in CTP as result is already published.
- 10 Jul 2014 New trial record